A Pilot Trial of Stepwise Implementation of Virtual Reality Mindfulness and Accelerated Transcranial Magnetic Stimulation Treatments for Dysphoria in Neuropsychiatric Disorders

Table 7

Paired -tests of primary clinician and self-rated scales from TMS treatment A1 to TMS follow-up A1 within diagnostic groups.

Measure	Mean		Std. error mean difference	Mean difference			Sig. (2-tailed)
	TxA1	FxA1
Depression
PHQ-9	17.53	12.93	1.5851	4.6000	2.902	14	.012
MADRS	31.67	22.00	2.6791	9.6667	3.608	14	.003
Anxiety
GAD-7	15.50	10.44	1.6342	5.0625	3.098	15	.007
HAM-A	24.19	16.94	2.3779	7.2500	3.049	15	.008
PTSD
PCL-5	55.38	32.63	8.4595	22.7500	2.689	7	.031
CAPS-5	46.13	30.75	5.9580	15.3750	2.581	7	.036
Chronic pain
PROMIS pain intensity	6.50	5.83	.3097	.6667	2.152	11	.054
PROMIS pain interference	16.17	16.25	.8657	-.0833	-.096	11	.925